Possible Interaction Between Topical Terbinafine and Acenocoumarol

被引:3
|
作者
Antonio Morales-Molina, Jose [1 ]
Angustias Molina Arrebola, M. [2 ]
Acosta Robles, Pedro [1 ]
Canto Mangana, Jose [1 ]
机构
[1] Empresa Publ Hosp Poniente, Dept Pharm, El Ejido 04700, Almeria, Spain
[2] Empresa Publ Hosp Poniente, Dept Hematol, El Ejido 04700, Almeria, Spain
关键词
ORAL TERBINAFINE; WARFARIN;
D O I
10.1345/aph.1M299
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1911 / 1912
页数:2
相关论文
共 50 条
  • [31] INVESTIGATION OF THE PHARMACOKINETICS OF ORAL AND TOPICAL TERBINAFINE
    LEVER, LR
    THOMAS, R
    DYKES, PJ
    MARKS, R
    FINLAY, AY
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 470 - 470
  • [32] TERBINAFINE - AN ORAL AND TOPICAL ANTIFUNGAL AGENT
    SHEAR, NH
    VILLARS, VV
    MARSOLAIS, C
    CLINICS IN DERMATOLOGY, 1991, 9 (04) : 487 - 495
  • [33] INVESTIGATION OF THE PHARMACOKINETICS OF ORAL AND TOPICAL TERBINAFINE
    LEVER, LR
    THOMAS, R
    DYKES, PJ
    MARKS, R
    FINLAY, AY
    CLINICAL RESEARCH, 1989, 37 (02): : A726 - A726
  • [34] Tinea capitis and topical Terbinafine cream
    Redondo-Mateo, J
    Esquivias-Gómez, JI
    Carrero-González, P
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (05) : 395 - 396
  • [35] Preparation, Characterisation, and Topical Delivery of Terbinafine
    Al Hossain, A. S. M. Monjur
    Sil, Bruno C.
    Iliopoulos, Fotis
    Lever, Rebecca
    Hadgraft, Jonathan
    Lane, Majella E.
    PHARMACEUTICS, 2019, 11 (10)
  • [36] POSSIBLE CARBAMAZEPINE TOXICITY WITH TERBINAFINE
    Baath, Navdeep S.
    Hong, Jennifer
    Sattar, S. Pirzada
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2006, 13 (02): : E228 - E231
  • [37] Rosuvastatin-acenocoumarol interaction
    Mondillo, S
    Ballo, P
    Galderisi, M
    CLINICAL THERAPEUTICS, 2005, 27 (06) : 782 - 784
  • [38] Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis
    Avner, S
    Nir, N
    Henri, T
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (5-6) : 327 - 330